New imaging study aims to sharpen radiotherapy for head and neck cancer

NCT ID NCT04612075

Recruiting now Knowledge-focused Sponsor: Norwegian University of Science and Technology Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether advanced PET/MR imaging can help doctors personalize radiotherapy for head and neck cancer. Researchers will scan 390 patients before, during, and after treatment to see if imaging details can predict survival and response. The goal is to improve outcomes and reduce side effects by tailoring radiation more precisely.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: FDG-PET/MRI (diagnostic imaging test)
What this could lead to: If successful, this could lead to more personalized radiotherapy for head and neck cancer, potentially improving survival and reducing side effects.
What could go wrong: This is an observational imaging study, not a treatment trial. It may not directly change patient outcomes, and results may take years to apply in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer head and neck neoplasm Head and Neck Neoplasms head and neck squamous cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEAD AND NECK NEOPLASMS

Contacts and locations

Locations

St Olavs Hospital, Department of Oncology
RECRUITING

Trondheim, Norway
University Hospital of North Norway
NOT_YET_RECRUITING

Tromsø, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.